logo-loader
HealthMedical technology & services
Correvio Pharma Corp

Correvio Pharma surges on Nasdaq as it completes share sale; continues to advance heart drug

Around 4.3 million shares were sold at an average price of US$2.71 each, resulting in net proceeds of around US$11.5 million

A heart pictured in a human hand
Atrial fibrillation is an irregular and often rapid heart rate

Shares in Correvio Pharma Corp (NASDAQ:CORV) surged over 26% Thursday in New York as it revealed it had netted around US$11.5 million from a share sale.

The Vancouver-based company now reckons it has enough cash to operate through the submission and U.S. Food and Drug Administration review of its new drug application filing for Brinavess.

READ: Correvio Pharma shares surge after preliminary test results in Europe on heart medication

Around 4.3 million shares were sold at an average price of US$2.71 each, resulting in net proceeds of around US$11.5 million.

Correvio is a speciality pharmaceutical company focused on commercializing hospital drugs.

Brinavess is used for treating atrial fibrillation, which is an irregular and often rapid heart rate that can increase the risk of stroke, heart failure and other complications.

Last September, the company reported safety data from a European study of the drug called Spectrum, where around 2,000 treatment episodes were reported by 53 hospitals in the European Union

Kiran Bhirangi, Correvio's vice-president for Clinical Development and Medical Affairs, had said: "In Spectrum, normal heart rhythm was restored in over 70% of patients at a median time of 11 minutes, HOIs (health outcomes of interest) were observed in 0.8% (17) of patients, and there were no deaths."

HOIs are defined as significant hypertension or irregular heartbeats.

Shares in Correvio on Nasdaq added 26.49% to US$2.88.

Contact Giles at [email protected]

Quick facts: Correvio Pharma Corp

Price: $2.04

Market: NASDAQ
Market Cap: $103.03 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks flat as a pancake but CROP shares jump on first...

Cannabis stocks cruised into Friday flat as a pancake across North American markets. Buds today were CROP Infrastructure Corp (CSE:CROP) (OTCMKTS:CRXPF), True Leaf Brands Inc (CSE:MJ) (OTCMKTS:TRLFF), while the duds were TerrAscend Corp (CSE:TER) (OTCMKTS:TRSSF),...

20 hours, 23 minutes ago

2 min read